HHS Urges Court To Reject Novo Nordisk Drug Plan Challenge

By Cassie M. Chew · January 29, 2024, 8:25 PM EST

The U.S. Department of Health and Human Services is asking a New Jersey federal judge to reject the challenge diabetes care drugmaker Novo Nordisk Inc. has been mounting against an effort...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Brief

Case Information

Case Title

NOVO NORDISK INC. et al v. BECERRA et al

Case Number

3:23-cv-20814

Court

New Jersey

Nature of Suit

Other Statutes: Administrative Procedures Act/Review or Appeal of Agency Decision

Date Filed

September 29, 2023

Recent Articles By Cassie

February 15, 2024
House Committee Blasts VA, Oracle For E-Record Failures
February 14, 2024
Settlements of 3 Drug Cos. Get Prelim OK In Price-Fixing MDL
February 12, 2024
FDA Seeks Comment On Guidance For Clinical Trial Sponsors
February 11, 2024
Rise In Billing For Catheters May Signal $2B Medicare Fraud
February 07, 2024
Existing Laws May Stymie AI Potential To Improve Healthcare
February 06, 2024
Proposed Rules in NY Target Anti-Competitive PBM Practices
February 05, 2024
Proposed Class Action Settlement May Cost Acella $46.5M
February 01, 2024
DOJ Looking For Privacy Perils In Digital Healthcare
January 31, 2024
FDA Has More Cyber Guidance Planned For Device Makers
January 26, 2024
COVID-19 Immunity Law Shields Hospital From Negligence